Cargando…
Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study
BACKGROUND: Malaria in pregnancy (MIP) has serious consequences for the woman, unborn child and newborn. The use of sulfadoxine-pyrimethamine for the intermittent preventive treatment of malaria in pregnancy (SP-IPTp) is low in malaria endemic areas, including some regions of Nigeria. However, littl...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857401/ https://www.ncbi.nlm.nih.gov/pubmed/27147109 http://dx.doi.org/10.1186/s12884-016-0883-2 |
_version_ | 1782430651997224960 |
---|---|
author | Ameh, Soter Owoaje, Eme Oyo-Ita, Angela Kabiru, Caroline W. Akpet, Obaji E. O. Etokidem, Aniekan Enembe, Okokon Ekpenyong, Nnette |
author_facet | Ameh, Soter Owoaje, Eme Oyo-Ita, Angela Kabiru, Caroline W. Akpet, Obaji E. O. Etokidem, Aniekan Enembe, Okokon Ekpenyong, Nnette |
author_sort | Ameh, Soter |
collection | PubMed |
description | BACKGROUND: Malaria in pregnancy (MIP) has serious consequences for the woman, unborn child and newborn. The use of sulfadoxine-pyrimethamine for the intermittent preventive treatment of malaria in pregnancy (SP-IPTp) is low in malaria endemic areas, including some regions of Nigeria. However, little is known about pregnant women’s compliance with the SP-IPTp national guidelines in primary health care (PHC) facilities in the south-south region of Nigeria. The aim of this study was to identify the barriers to and determinants of the use of SP-IPTp among pregnant women attending ANC in PHC facilities in Cross River State, south-south region of Nigeria. METHODS: A cross-sectional survey was conducted in 2011 among 400 ANC attendees aged 15–49 years recruited through multistage sampling. Binary logistic regression was used to determine the factors associated with the use of SP-IPTp in the study population. RESULTS: Use of SP-IPTp was self-reported by 41 % of the total respondents. Lack of autonomy in the households to receive sulfadoxine-pyrimethamine (SP) during ANC was the main barrier to use of IPTp (83 %). Other barriers were stock-outs of free SP (33 %) and poor supervision of SP ingestion by directly observed treatment among those who obtained SP from ANC clinics (36/110 = 33 %). In the multivariate logistic regression, the odds of using SP-IPTp was increased by the knowledge of the use of insecticide treated nets (ITNs) (OR = 2.13, 95 % CI: 1.70–3.73) and SP (OR = 22.13, 95 % CI: 8.10–43.20) for the prevention of MIP. Use of ITNs also increased the odds of using SP-IPTp (OR = 2.38, 95 % CI: 1.24–12.31). CONCLUSIONS: Use of SP-IPTp was low and was associated with knowledge of the use of ITNs and SP as well as the use of ITNs for the prevention of MIP. There is a need to strengthen PHC systems and address barriers to the usage of SP-IPTp in order to reduce the burden of MIP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12884-016-0883-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4857401 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48574012016-05-06 Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study Ameh, Soter Owoaje, Eme Oyo-Ita, Angela Kabiru, Caroline W. Akpet, Obaji E. O. Etokidem, Aniekan Enembe, Okokon Ekpenyong, Nnette BMC Pregnancy Childbirth Research Article BACKGROUND: Malaria in pregnancy (MIP) has serious consequences for the woman, unborn child and newborn. The use of sulfadoxine-pyrimethamine for the intermittent preventive treatment of malaria in pregnancy (SP-IPTp) is low in malaria endemic areas, including some regions of Nigeria. However, little is known about pregnant women’s compliance with the SP-IPTp national guidelines in primary health care (PHC) facilities in the south-south region of Nigeria. The aim of this study was to identify the barriers to and determinants of the use of SP-IPTp among pregnant women attending ANC in PHC facilities in Cross River State, south-south region of Nigeria. METHODS: A cross-sectional survey was conducted in 2011 among 400 ANC attendees aged 15–49 years recruited through multistage sampling. Binary logistic regression was used to determine the factors associated with the use of SP-IPTp in the study population. RESULTS: Use of SP-IPTp was self-reported by 41 % of the total respondents. Lack of autonomy in the households to receive sulfadoxine-pyrimethamine (SP) during ANC was the main barrier to use of IPTp (83 %). Other barriers were stock-outs of free SP (33 %) and poor supervision of SP ingestion by directly observed treatment among those who obtained SP from ANC clinics (36/110 = 33 %). In the multivariate logistic regression, the odds of using SP-IPTp was increased by the knowledge of the use of insecticide treated nets (ITNs) (OR = 2.13, 95 % CI: 1.70–3.73) and SP (OR = 22.13, 95 % CI: 8.10–43.20) for the prevention of MIP. Use of ITNs also increased the odds of using SP-IPTp (OR = 2.38, 95 % CI: 1.24–12.31). CONCLUSIONS: Use of SP-IPTp was low and was associated with knowledge of the use of ITNs and SP as well as the use of ITNs for the prevention of MIP. There is a need to strengthen PHC systems and address barriers to the usage of SP-IPTp in order to reduce the burden of MIP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12884-016-0883-2) contains supplementary material, which is available to authorized users. BioMed Central 2016-05-04 /pmc/articles/PMC4857401/ /pubmed/27147109 http://dx.doi.org/10.1186/s12884-016-0883-2 Text en © Ameh et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Ameh, Soter Owoaje, Eme Oyo-Ita, Angela Kabiru, Caroline W. Akpet, Obaji E. O. Etokidem, Aniekan Enembe, Okokon Ekpenyong, Nnette Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study |
title | Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study |
title_full | Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study |
title_fullStr | Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study |
title_full_unstemmed | Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study |
title_short | Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study |
title_sort | barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in cross river state, nigeria: a cross-sectional study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857401/ https://www.ncbi.nlm.nih.gov/pubmed/27147109 http://dx.doi.org/10.1186/s12884-016-0883-2 |
work_keys_str_mv | AT amehsoter barrierstoanddeterminantsoftheuseofintermittentpreventivetreatmentofmalariainpregnancyincrossriverstatenigeriaacrosssectionalstudy AT owoajeeme barrierstoanddeterminantsoftheuseofintermittentpreventivetreatmentofmalariainpregnancyincrossriverstatenigeriaacrosssectionalstudy AT oyoitaangela barrierstoanddeterminantsoftheuseofintermittentpreventivetreatmentofmalariainpregnancyincrossriverstatenigeriaacrosssectionalstudy AT kabirucarolinew barrierstoanddeterminantsoftheuseofintermittentpreventivetreatmentofmalariainpregnancyincrossriverstatenigeriaacrosssectionalstudy AT akpetobajieo barrierstoanddeterminantsoftheuseofintermittentpreventivetreatmentofmalariainpregnancyincrossriverstatenigeriaacrosssectionalstudy AT etokidemaniekan barrierstoanddeterminantsoftheuseofintermittentpreventivetreatmentofmalariainpregnancyincrossriverstatenigeriaacrosssectionalstudy AT enembeokokon barrierstoanddeterminantsoftheuseofintermittentpreventivetreatmentofmalariainpregnancyincrossriverstatenigeriaacrosssectionalstudy AT ekpenyongnnette barrierstoanddeterminantsoftheuseofintermittentpreventivetreatmentofmalariainpregnancyincrossriverstatenigeriaacrosssectionalstudy |